{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:00:35Z","timestamp":1790521235847,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Plan Cancer","award":["BIO2004-06"],"award-info":[{"award-number":["BIO2004-06"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Bioenergetics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbabio.2017.02.005","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T09:16:33Z","timestamp":1487236593000},"page":"674-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy"],"prefix":"10.1016","volume":"1858","author":[{"given":"N.D.","family":"Amoedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Obre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbabio.2017.02.005_bb0005","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2016.02.018","article-title":"mTORC1-dependent metabolic reprogramming underlies escape from glycolysis addiction in cancer cells","volume":"29","author":"Pusapati","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0010","article-title":"Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism","author":"Cacace","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nature14362","article-title":"Fatty acid carbon is essential for dNTP synthesis in endothelial cells","volume":"520","author":"Schoors","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","article-title":"Reductive carboxylation supports growth in tumour cells with defective mitochondria","volume":"481","author":"Mullen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cmet.2011.04.012","article-title":"13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression","volume":"14","author":"Hu","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0045","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0050","first-page":"6674","article-title":"The bioenergetic signature of cancer: a marker of tumor progression","volume":"62","author":"Cuezva","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.1156906","article-title":"ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis","volume":"320","author":"Ishikawa","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2014.06.043","article-title":"A mitochondrial switch promotes tumor metastasis","author":"Porporato","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0065","article-title":"Enhanced OXPHOS, glutaminolysis and beta-oxidation constitute the metastatic phenotype of melanoma cells","author":"Rodrigues","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0070","doi-asserted-by":"crossref","first-page":"dju327","DOI":"10.1093\/jnci\/dju327","article-title":"Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival","volume":"106","author":"Johansson","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/febs.13535","article-title":"Understanding the cancer cell phenotype beyond the limitations of current omics analyses","volume":"283","author":"Moreno-S\u00e1nchez","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0080","doi-asserted-by":"crossref","first-page":"1428271","DOI":"10.1155\/2016\/1428271","article-title":"Differentially expressed miRNAs in tumor, adjacent, and normal tissues of lung adenocarcinoma","volume":"2016","author":"Tian","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0085","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1055-9965.EPI-14-0934","article-title":"Tumor intrinsic subtype is reflected in cancer-adjacent tissue","volume":"24","author":"Casbas-Hernandez","year":"2015","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0090","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-016-2223-3","article-title":"On predicting lung cancer subtypes using \u201comic\u201d data from tumor and tumor-adjacent histologically-normal tissue","volume":"16","author":"Pineda","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0095","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cmet.2014.12.003","article-title":"Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA","volume":"21","author":"Tan","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0105","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.cmet.2016.05.027","article-title":"Effects of sex, strain, and energy intake on hallmarks of aging in mice","volume":"23","author":"Mitchell","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0110","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.15252\/emmm.201606798","article-title":"Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities","volume":"8","author":"Goveia","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0115","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMc090593","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"De Carli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0120","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/nature09132","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"465","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0125","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cmet.2012.05.001","article-title":"Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo","volume":"15","author":"Marin-Valencia","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0130","series-title":"Metabolism of Tumors","author":"Warburg","year":"1930"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0135","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0140","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cell.2015.12.034","article-title":"Metabolic heterogeneity in human lung tumors","volume":"164","author":"Hensley","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0145","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neo.2016.10.010","article-title":"Multimodality imaging identifies distinct metabolic profiles in vitro and in vivo","volume":"18","author":"Neveu","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0150","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbabio.2017.01.002","article-title":"Manipulation of tumor oxygenation and radiosensitivity through modification of cell respiration. A critical review of approaches and imaging biomarkers for therapeutic guidance","volume":"1858","author":"Gallez","year":"2017","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0155","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature13438","article-title":"Proteogenomic characterization of human colon and rectal cancer","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0160","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1073\/pnas.1523434113","article-title":"Quantitative proteomics and phosphoproteomics on serial tumor biopsies from a sorafenib-treated HCC patient","volume":"113","author":"Dazert","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0165","doi-asserted-by":"crossref","first-page":"aad0189","DOI":"10.1126\/science.aad0189","article-title":"Systems proteomics of liver mitochondria function","volume":"352","author":"Williams","year":"2016","journal-title":"Science"},{"issue":"Pt 1","key":"10.1016\/j.bbabio.2017.02.005_bb0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj3470045","article-title":"Tissue variation in the control of oxidative phosphorylation: implication for mitochondrial diseases","volume":"347","author":"Rossignol","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0175","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1042\/bj20021594","article-title":"Mitochondrial threshold effects","volume":"370","author":"Rossignol","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0180","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.biocel.2007.11.023","article-title":"Functional dynamic compartmentalization of respiratory chain intermediate substrates: implications for the control of energy production and mitochondrial diseases","volume":"40","author":"Benard","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nbt0302-243","article-title":"Metabolic control analysis in drug discovery and disease","volume":"20","author":"Cascante","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0190","doi-asserted-by":"crossref","first-page":"33426","DOI":"10.1074\/jbc.274.47.33426","article-title":"Threshold effect and tissue specificity","volume":"274","author":"Rossignol","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0195","article-title":"Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy","author":"Obre","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0200","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1038\/ncomms6469","article-title":"Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact","volume":"5","author":"Li","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature16967","article-title":"Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities","volume":"531","author":"Kerr","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0215","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","article-title":"MYC\/PGC-1\u03b1 balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells","volume":"22","author":"Sancho","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0220","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0225","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/stem.2286","article-title":"Metabolic reprogramming and dependencies associated with epithelial cancer stem cells independent of the epithelial-mesenchymal transition program","volume":"34","author":"Aguilar","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0230","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1158\/0008-5472.CAN-09-2266","article-title":"Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.exphem.2013.12.001","article-title":"Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations","volume":"42","author":"Emadi","year":"2014","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0240","article-title":"High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy","author":"Imasawa","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0245","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0092-8674(00)00046-5","article-title":"Cellular senescence: mitotic clock or culture shock?","volume":"102","author":"Sherr","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0250","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0255","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI72873","article-title":"Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation","volume":"125","author":"Sellers","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0260","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1016627108","article-title":"Pyruvate carboxylase is required for glutamine-independent growth of tumor cells","volume":"108","author":"Cheng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0265","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fbioe.2016.00072","article-title":"Fluid dynamic modeling to support the development of flow-based hepatocyte culture systems for metabolism studies","volume":"4","author":"Pedersen","year":"2016","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0270","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1158\/0008-5472.CAN-12-3040","article-title":"Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer","volume":"73","author":"Tahir","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0275","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","article-title":"Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer","volume":"23","author":"Davidson","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0280","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1073\/pnas.0700690104","article-title":"Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production","author":"Funes","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0285","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0290","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1158\/0008-5472.CAN-14-1606","article-title":"Modeling lung cancer evolution and preclinical response by orthotopic mouse allografts","volume":"74","author":"Ambrogio","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0295","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1073\/pnas.1003428107","article-title":"Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity","volume":"107","author":"Weinberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0300","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcb.2013.07.010","article-title":"Changing appetites: the adaptive advantages of fuel choice","volume":"24","author":"Stanley","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0305","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1158\/1078-0432.CCR-15-0375","article-title":"Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer","volume":"21","author":"De Rosa","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-015-0138-0","article-title":"Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth","volume":"3","author":"Sch\u00f6ckel","year":"2015","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0315","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-15-0089","article-title":"Resistance to epidermal growth factor receptor tyrosine kinase inhibitor in non-small cell lung cancer","author":"Jang","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0320","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","article-title":"PGC1\u03b1 expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress","volume":"23","author":"Vazquez","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0325","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0330","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cmet.2011.12.015","article-title":"The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type","volume":"15","author":"Yuneva","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0340","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cmet.2012.05.001","article-title":"Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo","volume":"15","author":"Marin-Valencia","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0345","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-8-41","article-title":"Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM)","volume":"8","author":"Fan","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbabio.2017.02.005_bb0350","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1038\/ncomms13041","article-title":"Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival","volume":"7","author":"Gaude","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0355","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4161\/cbt.21348","article-title":"Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth","volume":"13","author":"van den Heuvel","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0360","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2016.01.007","article-title":"Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer","volume":"23","author":"Davidson","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0365","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1073\/pnas.1003428107","article-title":"Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity","volume":"107","author":"Weinberg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2015.01.003","article-title":"Energy metabolism disorders in rare and common diseases. Toward bioenergetic modulation therapy and the training of a new generation of European scientists","author":"Rossignol","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0375","article-title":"Targeting increased anaplerotic metabolism of pathogenic T cells to treat immune disease","author":"Glick","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbabio.2017.02.005_bb0380","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrg.2016.12","article-title":"The genetics of drug efficacy: opportunities and challenges","volume":"17","author":"Nelson","year":"2016","journal-title":"Nat. Rev. Genet."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Bioenergetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005272817300270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0005272817300270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:55:36Z","timestamp":1617324936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0005272817300270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0005272817300270"],"URL":"https:\/\/doi.org\/10.1016\/j.bbabio.2017.02.005","relation":{},"ISSN":["0005-2728"],"issn-type":[{"value":"0005-2728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Bioenergetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbabio.2017.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}